Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
463 JPY | +2.21% | -0.22% | -19.90% |
05-09 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
03-13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
- Stock Market
- Equities
- 4599 Stock
- News StemRIM
- Transcripts